Diseases, Conditions, Syndromes

Novavax enters late-stage clinical trials

US biotech firm Novavax said Thursday it was initiating its final Phase 3 clinical trial for its experimental COVID-19 vaccine.

Medical research

Active substance from plant slows down aggressive eye cancer

An active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors. This is shown by a study conducted by researchers from the Universities of Bonn and Magdeburg together with ...

Diseases, Conditions, Syndromes

Researchers develop prototype chikungunya vaccine

Wageningen University in the Netherlands has developed a prototype vaccine against chikungunya in a joint effort with the Erasmus Medical Centre and TI Pharma. This prototype may hopefully lead to the first working vaccine ...

Medical research

Mosquito virus could lead to new vaccines and drugs

A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens ...

Cardiology

Discovery may lead to targeted heart disease treatments

University of Guelph researchers have found the location and effect of abnormal heart proteins that can cause cardiac failure, a discovery that points to potential new ways to treat the most costly health problem in the world.

Medical research

Cross-reactive antibodies vanquish H5N1 in preclinical study

The H5N1 influenza has proven extraordinarily deadly. More than 50 percent of the 500 cases that have been documented since the virus first emerged in 1997 have been fatal. Thus, H5N1 is viewed as a serious threat to world ...

page 1 from 2